Skip to main content

Table 7 Working statusa during ABC treatment for patients <65 years of age

From: Patterns of resource utilization and cost for postmenopausal women with hormone-receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in Europe

 

Patients, n (%)

 

Full-time work

Part-time work

Sick leave

Retired early

Cohort A

    

 ABC diagnosis (n = 109)

26 (24)

21 (19)

6 (6)

7 (6)

 1st-line hormone therapy (n = 109)

13 (12)

22 (20)

21 (19)

8 (7)

 2nd-line chemotherapy (n = 109)

2 (2)

9 (8)

45 (41)

10 (9)

 3rd-line any therapy (n = 39)

1 (3)

2 (5)

16 (41)

5 (13)

Cohort C

    

 ABC diagnosis (n = 70)

26 (37)

13 (19)

5 (7)

4 (6)

 1st-line chemotherapy (n = 70)

6 (9)

12 (17)

29 (41)

4 (6)

 2nd-line any therapy (n = 70)

8 (11)

8 (11)

29 (41)

6 (9)

 3rd-line any therapy (n = 27)

2 (7)

1 (4)

14 (52)

2 (7)

  1. Abbreviation: ABC advanced breast cancer
  2. aThe percentages of patients do not add to 100 % because the working status categories of voluntary work, unemployed, retired, and unknown did not have appreciable changes within the cohorts over time and are not presented